During the past decade, Palmetto Clinical Research conducted 22 clinical trials. In the 10-year time frame, 22 clinical trials started and 20 clinical trials were completed, i.e. on average, 90.9% percent of trials that started reached the finish line to date. In the past 5 years, 15 clinical trials started and 8 clinical trials were completed. i.e. 53.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Palmetto Clinical Research" #1 sponsor was "Pfizer" with 6 trials, followed by "AstraZeneca" with 4 trials sponsored, "Bristol-Myers Squibb" with 2 trials sponsored, "Urovant Sciences GmbH" with 2 trials sponsored and "Amgen" with 2 trials sponsored. Other sponsors include 14 different institutions and companies that sponsored additional 24 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Palmetto Clinical Research" #1 collaborator was "Bristol-Myers Squibb" with 4 trials as a collaborator, "Pfizer" with 2 trials as a collaborator, "Alzheimer's Association" with 1 trials as a collaborator, "Brigham and Women's Hospital" with 1 trials as a collaborator and "Clinilabs, Inc." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Palmetto Clinical Research" are "Type 2 Diabetes" (3 trials), "Alzheimer Disease" (2 trials), "Diabetes Mellitus, Type 2" (2 trials), "Hyperlipidemia" (2 trials) and "Obesity" (2 trials). Many other conditions were trialed in "Palmetto Clinical Research" in a lesser frequency.

Most popular intervention types in "Palmetto Clinical Research" are "Drug" (32 trials), "Other" (2 trials), "Biological" (1 trials) and "Combination Product" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (20 trials), "Dapagliflozin" (4 trials), "PF-06882961" (2 trials), "Tolterodine Tartrate ER" (2 trials) and "15mg T3D-959" (1 trials). Other intervention names were less common.

The vast majority of trials in "Palmetto Clinical Research" are 30 trials for "All" genders and 4 trials for "Female" genders.

Currently, there are NaN active trials in "Palmetto Clinical Research". undefined are not yet recruiting, 2 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 25 completed trials in Palmetto Clinical Research, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Palmetto Clinical Research, 0 "Phase 1" clinical trials were conducted, 13 "Phase 2" clinical trials and 21 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".